¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"specific antigen"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
specific rotation
1. ºñ¼±±¤µµ 2. °íÀ¯±¤È¸Àüµµ
specific serotonin reuptake inhibitor
ƯÀ̼¼·ÎÅä´ÑÀçÈí¼ö¾ïÁ¦Á¦
specific serum
ƯÀÌÇ÷û
specific soluble substance
ƯÀ̰¡¿ë¹°Áú
stage-specific protein
¹ßÀ°´Ü°èƯÀ̴ܹéÁú
antigen
Ç׿ø
antigen analysis
Ç׿øºÐ¼®
antigen binding capacity
Ç׿ø°áÇÕ´É
antigen binding fragment
Ç׿ø°áÇÕºÎÀ§
antigen binding receptor
Ç׿ø°áÇÕ¼ö¿ëü
antigen capture assay
Ç׿øÆ÷È¹ÃøÁ¤
antigen competition
Ç׿ø°æÀï
antigen diffusion constant
Ç׿øÈ®»ê»ó¼ö
antigen excess
Ç׿ø°úÀ×
antigen excess zone
Ç׿ø°úÀ×±¸¿ª
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
specific morbidity rate
ƯÀÌÀÌȯÀ²
specific mortality rate
ƯÀÌ»ç¸Á·ü
specific reading retardation
ƯÁ¤ÀбâÁö¿¬
specific
ƯÀÌ-, ƯÁ¤-
specific serum
ƯÀÌÇ÷û
specific gravity test
ºñÁß½ÃÇè
specific soluble substance
ƯÀ̰¡¿ë¹°Áú
virus-specific
¹ÙÀÌ·¯½ºÆ¯ÀÌ-
antigen
Ç׿ø
accessible antigen
Á¢±Ù°¡´ÉÇ׿ø
antigen competition
Ç׿ø°æÀï
antigen excess
Ç׿ø°úÀ×
antigen mimicry
Ç׿øÀ¯»ç¼º
antigen modification
Ç׿øº¯È, Ç׿ø¼ö½Ä
antigen presentation
Ç׿øÀü´Þ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
Fy antigen/antibody
Fy Ç׿ø/Ç×ü
Gag => group specifiic antigen/core
±×·ì<±º>ƯÀ̼º Ç׿ø/ÄÚ¾î
Gag antigen in HIV infection
HIV °¨¿°ÀÇ gag Ç׿ø
Gag antigen:
gag Ç׿ø
H antigen
H Ç׿ø
H antigen
HÇ׿ø, Æí¸ðÇ׿ø
H-Y histocompatibility antigen
H-Y Á¶Á÷ÀûÇÕ¼º Ç׿ø
HBc Ag => hepatitis B core antigen
B Çü °£¿° c Ç׿ø
HBc antigen
BÇü °£¿°¹ÙÀÌ·¯½º ÇÙ½ÉÇ׿ø
HBe Ag => hepatitis B e antigen
B Çü °£¿° e Ç׿ø
HBe antigen
BÇü °£¿°¹ÙÀÌ·¯½º eÇ׿ø
HBs antigen
BÇü °£¿°¹ÙÀÌ·¯½º Ç¥¸éÇ׿ø
HBsAg => hepatitis B surface antigen
B Çü °£¿° s Ç׿ø
HDAg => hepatitis D antigen
D Çü °£¿°Ç׿ø
HLA => human leukocyte antigen
ÀÎüÁ¶Á÷ÀûÇÕÇ׿ø<ÀÎü¹éÇ÷±¸Ç׿ø>
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
specific absorption ratio, SAR
Ư¼ºÈí¼öÀ²
specific acid
ƯÀÌ»ê(÷åì¶ß«).
specific action
ƯÀÌÀÛ¿ë(÷åì¶íÂéÄ).
specific activity
ƯÀÌȰ¼º[µµ], ºñ[Ýï]Ȱ¼º[µµ]
specific activity
ºñ¹æ»ç´É
specific adhesion
°íÀ¯Á¢Âø(ͳêóïÈó·).
specific antagonist
ƯÀÌÀû ±æÇ×Á¦(÷åì¶îÜÑÏù÷ð¥).
specific blood group substance
ƯÀÌÇ÷¾×Çü¹°Áú(¡úìäûúþÚªòõ).
specific blood group substance
ƯÀÌÇ÷¾×Çü¹°Áú(¡úìäûúþÚªòõ)
specific blood group substance
ƯÀÌÇ÷¾×Çü¹°Áú(?Ì´ËâÌ´?̤).
specific capsular reaction
ƯÀÌÇù¸·¹ÝÀÀ (¡úõدÚãëë).
specific capsular reaction
ƯÀÌÇù¸·¹ÝÀÀ (¡úõدÚãëë).
specific cellular immunity
ƯÀÌÀû ¼¼Æ÷¸é¿ª (¡îÜá¬øàØóæ¹).
specific cellular immunity
ƯÀÌÀû ¼¼Æ÷¸é¿ª (¡îÜá¬øàØóæ¹).
specific charge
ºñÀüÇÏ(Ýïï³ùÃ).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½